Fulminant myocarditis due to H1N1 influenza

Circulation: Heart Failure

Volumn 3, Issue 3, 2010, Pages

  Mohammed, Al Amoodi ^a   Rao, Kavitha ^a   Rao, Seshu ^a   Brewer, Joseph H ^a   Magalski, Anthony ^a   Chhatriwalla, Adnan K ^b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b America Heart Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CEFTRIAXONE; DOPAMINE; MILRINONE; NORADRENALIN; OSELTAMIVIR; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; FEVER; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; INFLUENZA A (H1N1); MALE; MYOCARDITIS; PERICARDIAL EFFUSION; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; VIROLOGY;

ADULT; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDITIS;

EID: 77954711246     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.110.938506     Document Type: Article

References (4)

1. World Health Organization. Influenza A (H1N1)-update 49. 2009. Available at: http://www.who.int/csr/don/2009-06-15/en/index.html.Accessed October 29, 2009.
2. The President's Council of Advisors on Science and Technology Executive report. U.S Preparation for 2009-H1N1 influenza. 2009. Avaliable at: http://www.whitehouse.gov/assets/documents/PCAST-H1N1-Report.pdf Accessed September 16, 2009.
3. Onitsuka H, Imamura T, Miyamoto N. Clinical manifestations of influenza myocarditis during the influenza epidemic of winter 1998-1999. J Cardiol. 2001;37:315-323.
4. Kato S, Morimoto S, Hiramitsu S, Nomura M, Ito T, Hishida H. Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis. Am J Cardiol. 1999;83:623-625.